PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 68 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $20,918 | +326.5% | 17,879 | +359.3% | 0.00% | – |
Q1 2024 | $4,905 | -76.9% | 3,893 | -67.4% | 0.00% | – |
Q4 2023 | $21,239 | +89.5% | 11,932 | +76.7% | 0.00% | – |
Q3 2023 | $11,210 | +116.2% | 6,753 | +160.5% | 0.00% | – |
Q2 2023 | $5,184 | +172700.0% | 2,592 | +61.8% | 0.00% | – |
Q1 2023 | $3 | -100.0% | 1,602 | -75.2% | 0.00% | – |
Q1 2022 | $7,000 | – | 6,465 | +8879.2% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 72 | -98.5% | 0.00% | – |
Q2 2021 | $9,000 | +80.0% | 4,658 | +328.1% | 0.00% | – |
Q1 2021 | $5,000 | – | 1,088 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ground Swell Capital, LLC | 62,234 | $72,814 | 0.06% |
Orin Green Financial, LLC | 72,000 | $84,240 | 0.04% |
GSA CAPITAL PARTNERS LLP | 401,244 | $469 | 0.03% |
Point72 Asia (Singapore) Pte. Ltd. | 68,163 | $79,751 | 0.02% |
CAPITAL PERFORMANCE ADVISORS LLP | 26,793 | $31,348 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 158,259 | $185,163 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,790 | $215,034 | 0.01% |
HARBOUR INVESTMENT MANAGEMENT LLC | 10,100 | $11,817 | 0.01% |
MIRABELLA FINANCIAL SERVICES LLP | 30,000 | $35,100 | 0.00% |
Centiva Capital, LP | 130,332 | $152,488 | 0.00% |